Cargando…

Mumps, 2016: A National Overview

BACKGROUND: Mumps is an acute viral illness that classically presents with parotitis. Infected persons who are asymptomatic or have non-specific respiratory symptoms can still transmit disease. Recently, mumps cases and outbreaks (OB) among young adults (18-22 years) in the US have been increasing....

Descripción completa

Detalles Bibliográficos
Autores principales: Clemmons, Nakia, Lee, Adria, Redd, Susan B, Routh, Janell, Patel, Manisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631715/
http://dx.doi.org/10.1093/ofid/ofx163.510
_version_ 1783269540754358272
author Clemmons, Nakia
Lee, Adria
Redd, Susan B
Routh, Janell
Patel, Manisha
author_facet Clemmons, Nakia
Lee, Adria
Redd, Susan B
Routh, Janell
Patel, Manisha
author_sort Clemmons, Nakia
collection PubMed
description BACKGROUND: Mumps is an acute viral illness that classically presents with parotitis. Infected persons who are asymptomatic or have non-specific respiratory symptoms can still transmit disease. Recently, mumps cases and outbreaks (OB) among young adults (18-22 years) in the US have been increasing. In 2016, university and close-knit community OB accounted for the highest incidence rates (IR) since 2006 (Figure 1). METHODS: The Centers for Disease Control and Prevention (CDC) assessed reports of confirmed and probable mumps cases transmitted through passive surveillance by 52 state/local health departments (jurisdictions). Nine jurisdictions submitted enhanced OB data including symptoms and complications directly to CDC. We calculated overall and age-specific IR (per 1,000,000 persons, 95% CI) by dividing the annual number of mumps cases by U.S. Census Bureau’s population estimates. SAS (v9.4) was used for analysis. RESULTS: From January–December 31, 2016, 5,724 mumps cases from 48 jurisdictions were reported (overall IR: 18). Of 79% with vaccination status, 88% had ≥1 dose and 60% had ≥2 doses of measles mumps rubella (MMR) vaccine. Median age was 20 years (range: <1–88 years). Incidence rates significantly increased for all age groups from 2011 to 2016 (1.2 (CI: 1.2–1.4) to 18 (17–18), P < 0.0001). IR in young adults increased from 4.1 (CI: 3.3–5.0) to 70 (CI: 66–73), P < .0001 (Figure 2). Twenty-nine jurisdictions reported mumps OB (defined as ≥3 cases linked by time/space); OB accounted for ~81% of all cases. Two states, Arkansas and Iowa, contributed 53% of all cases. Among jurisdictions with enhanced OB data, 20 OB (median 12 cases, range: 3–685) with a total of 1379 outbreak cases were reported. Parotitis was reported in 99% of cases. Complications were low: orchitis was reported in 7% of males and oophoritis in 2% of females; ≤1% reported hearing loss, mastitis, encephalitis or pancreatitis. Average report time from symptom onset to health department was 6 days. Ten OB had population vaccination coverage ≥85%. CONCLUSION: OB contributed to a significant increase in mumps incidence in 2016. Although most cases occurred in young adults vaccinated with 2 doses during childhood thus suggesting waning immunity, complications remain rare. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5631715
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56317152017-11-07 Mumps, 2016: A National Overview Clemmons, Nakia Lee, Adria Redd, Susan B Routh, Janell Patel, Manisha Open Forum Infect Dis Abstracts BACKGROUND: Mumps is an acute viral illness that classically presents with parotitis. Infected persons who are asymptomatic or have non-specific respiratory symptoms can still transmit disease. Recently, mumps cases and outbreaks (OB) among young adults (18-22 years) in the US have been increasing. In 2016, university and close-knit community OB accounted for the highest incidence rates (IR) since 2006 (Figure 1). METHODS: The Centers for Disease Control and Prevention (CDC) assessed reports of confirmed and probable mumps cases transmitted through passive surveillance by 52 state/local health departments (jurisdictions). Nine jurisdictions submitted enhanced OB data including symptoms and complications directly to CDC. We calculated overall and age-specific IR (per 1,000,000 persons, 95% CI) by dividing the annual number of mumps cases by U.S. Census Bureau’s population estimates. SAS (v9.4) was used for analysis. RESULTS: From January–December 31, 2016, 5,724 mumps cases from 48 jurisdictions were reported (overall IR: 18). Of 79% with vaccination status, 88% had ≥1 dose and 60% had ≥2 doses of measles mumps rubella (MMR) vaccine. Median age was 20 years (range: <1–88 years). Incidence rates significantly increased for all age groups from 2011 to 2016 (1.2 (CI: 1.2–1.4) to 18 (17–18), P < 0.0001). IR in young adults increased from 4.1 (CI: 3.3–5.0) to 70 (CI: 66–73), P < .0001 (Figure 2). Twenty-nine jurisdictions reported mumps OB (defined as ≥3 cases linked by time/space); OB accounted for ~81% of all cases. Two states, Arkansas and Iowa, contributed 53% of all cases. Among jurisdictions with enhanced OB data, 20 OB (median 12 cases, range: 3–685) with a total of 1379 outbreak cases were reported. Parotitis was reported in 99% of cases. Complications were low: orchitis was reported in 7% of males and oophoritis in 2% of females; ≤1% reported hearing loss, mastitis, encephalitis or pancreatitis. Average report time from symptom onset to health department was 6 days. Ten OB had population vaccination coverage ≥85%. CONCLUSION: OB contributed to a significant increase in mumps incidence in 2016. Although most cases occurred in young adults vaccinated with 2 doses during childhood thus suggesting waning immunity, complications remain rare. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631715/ http://dx.doi.org/10.1093/ofid/ofx163.510 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Clemmons, Nakia
Lee, Adria
Redd, Susan B
Routh, Janell
Patel, Manisha
Mumps, 2016: A National Overview
title Mumps, 2016: A National Overview
title_full Mumps, 2016: A National Overview
title_fullStr Mumps, 2016: A National Overview
title_full_unstemmed Mumps, 2016: A National Overview
title_short Mumps, 2016: A National Overview
title_sort mumps, 2016: a national overview
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631715/
http://dx.doi.org/10.1093/ofid/ofx163.510
work_keys_str_mv AT clemmonsnakia mumps2016anationaloverview
AT leeadria mumps2016anationaloverview
AT reddsusanb mumps2016anationaloverview
AT routhjanell mumps2016anationaloverview
AT patelmanisha mumps2016anationaloverview